newsfilter
← Latest News
GlobeNewswire·

Codiak BioSciences to Participate at William Blair Biotech Focus Conference 2022

CAMBRIDGE, Mass., July 11, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (NASDAQ:CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that management